Nanologica AB Cash Flow-to-Debt Ratio
Nanologica AB cash flow-to-debt ratio. Nanologica AB (NICA) has a Cash Flow-to-Debt Ratio of -0.04x as of March 2026, meaning its operating cash flow of Skr-6.22 Million could theoretically repay 0% of its total liabilities (Skr164.82 Million) in one year. Check Nanologica AB cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Nanologica AB (2015–2025)
Cash flow-to-debt ratio of Nanologica AB from 2015 to 2025. Historical debt coverage capacity for Nanologica AB across 11 annual periods. Check NICA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Nanologica AB Cash Flow-to-Debt Ratio by Year (2015–2025)
Nanologica AB cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for Nanologica AB. For the full cash flow conversion analysis, see NICA cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.61x | Skr-39.88 Million | Skr65.47 Million | ▲ +47.9% |
| 2024 | -1.17x | Skr-80.73 Million | Skr68.99 Million | ▼ -159.0% |
| 2023 | -0.45x | Skr-35.85 Million | Skr79.33 Million | ▲ +18.7% |
| 2022 | -0.56x | Skr-45.22 Million | Skr81.36 Million | ▲ +44.1% |
| 2021 | -1.00x | Skr-46.49 Million | Skr46.72 Million | ▼ -22.6% |
| 2020 | -0.81x | Skr-43.34 Million | Skr53.38 Million | ▼ -168.9% |
| 2019 | -0.30x | Skr-11.52 Million | Skr38.16 Million | ▲ +72.6% |
| 2018 | -1.10x | Skr-11.71 Million | Skr10.62 Million | ▼ -13.9% |
| 2017 | -0.97x | Skr-23.19 Million | Skr23.98 Million | ▲ +59.0% |
| 2016 | -2.36x | Skr-23.19 Million | Skr9.84 Million | ▼ -45.8% |
| 2015 | -1.62x | Skr-13.95 Million | Skr8.63 Million | — |